...
search icon
kala-img

Kala Pharmaceuticals Inc Share Price

KALA
NAQ
$0.3633
-$0.04
(-10.01%)
1D
Industry: Pharmaceuticals Sector: Health Care

Kala Pharmaceuticals Inc Analyst Forecast

Kala Pharmaceuticals Inc Share Price Chart

Kala Pharmaceuticals Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$364.35M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
873.87K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-2.44
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.38 L
$20.6 H
$0.3633

About Kala Pharmaceuticals Inc, Common Stock

KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases. The company's lead product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; and limbal stem cell deficiency and other rare corneal diseases. Its preclinical development product consists of KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts. more

Industry: PharmaceuticalsSector: Health Care

Kala Pharmaceuticals Inc Stock Returns

Time FrameKALASectorS&P500
1-Week Return-8.95%0.91%2.13%
1-Month Return-43.23%-0.72%-0.47%
3-Month Return-49.99%2.24%1.29%
6-Month Return-95.12%19.1%7.71%
1-Year Return-95.12%7.15%14.7%
3-Year Return-97.16%16.96%67.75%
5-Year Return-99.92%33.23%76.25%
10-Year Return-99.96%142.74%271.83%

Kala Pharmaceuticals Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue6.36M11.24M3.89M--[{"date":"2020-12-31","value":56.6,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":34.63,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue3.17M4.10M2.56M303.00K259.00K[{"date":"2020-12-31","value":77.45,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":62.48,"profit":true},{"date":"2023-12-31","value":7.4,"profit":true},{"date":"2024-12-31","value":6.32,"profit":true}]
Gross Profit3.19M7.14M1.33M(303.00K)(259.00K)[{"date":"2020-12-31","value":44.65,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":18.65,"profit":true},{"date":"2023-12-31","value":-4.24,"profit":false},{"date":"2024-12-31","value":-3.63,"profit":false}]
Gross Margin50.13%63.55%34.22%--[{"date":"2020-12-31","value":78.88,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":53.85,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses99.42M116.58M82.69M38.85M40.17M[{"date":"2020-12-31","value":85.28,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":70.93,"profit":true},{"date":"2023-12-31","value":33.33,"profit":true},{"date":"2024-12-31","value":34.46,"profit":true}]
Operating Income(96.23M)(109.43M)(81.36M)(39.15M)(40.98M)[{"date":"2020-12-31","value":-9623100000,"profit":false},{"date":"2021-12-31","value":-10943300000,"profit":false},{"date":"2022-12-31","value":-8135600000,"profit":false},{"date":"2023-12-31","value":-3915300000,"profit":false},{"date":"2024-12-31","value":-4098300000,"profit":false}]
Total Non-Operating Income/Expense(16.19M)(41.45M)29.93M(6.51M)(1.25M)[{"date":"2020-12-31","value":-54.1,"profit":false},{"date":"2021-12-31","value":-138.47,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-21.76,"profit":false},{"date":"2024-12-31","value":-4.19,"profit":false}]
Pre-Tax Income(104.33M)(142.60M)(44.82M)(42.20M)(38.51M)[{"date":"2020-12-31","value":-10432700000,"profit":false},{"date":"2021-12-31","value":-14260500000,"profit":false},{"date":"2022-12-31","value":-4482200000,"profit":false},{"date":"2023-12-31","value":-4219900000,"profit":false},{"date":"2024-12-31","value":-3851100000,"profit":false}]
Income Taxes7.68M9.69M(44.60M)--[{"date":"2020-12-31","value":79.22,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-460.21,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(112.00M)(152.30M)(223.00K)--[{"date":"2020-12-31","value":-11200400000,"profit":false},{"date":"2021-12-31","value":-15229600000,"profit":false},{"date":"2022-12-31","value":-22300000,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(96.23M)(142.60M)(44.82M)(46.41M)(38.51M)[{"date":"2020-12-31","value":-9623100000,"profit":false},{"date":"2021-12-31","value":-14260500000,"profit":false},{"date":"2022-12-31","value":-4482200000,"profit":false},{"date":"2023-12-31","value":-4641500000,"profit":false},{"date":"2024-12-31","value":-3851100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(104.33M)(142.60M)(44.82M)(42.20M)(38.51M)[{"date":"2020-12-31","value":-10432700000,"profit":false},{"date":"2021-12-31","value":-14260500000,"profit":false},{"date":"2022-12-31","value":-4482200000,"profit":false},{"date":"2023-12-31","value":-4219900000,"profit":false},{"date":"2024-12-31","value":-3851100000,"profit":false}]
EPS (Diluted)(100.50)(108.50)(30.22)(17.94)(10.52)[{"date":"2020-12-31","value":-10050,"profit":false},{"date":"2021-12-31","value":-10850,"profit":false},{"date":"2022-12-31","value":-3022,"profit":false},{"date":"2023-12-31","value":-1794,"profit":false},{"date":"2024-12-31","value":-1051.57,"profit":false}]

Kala Pharmaceuticals Inc Ratios

Kala Pharmaceuticals Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

KALA
Cash Ratio 0.65
Current Ratio 0.75

Kala Pharmaceuticals Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

KALA
ROA (LTM) -65.81%
ROE (LTM) -708.34%

Kala Pharmaceuticals Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

KALA
Debt Ratio Lower is generally better. Negative is bad. 0.04
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.35

Kala Pharmaceuticals Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

KALA
Trailing PE NM
Forward PE NM
P/S (TTM) 1.16
P/B 8.34
Price/FCF NM
EV/R 0.04
EV/Ebitda NM
PEG NM

FAQs

What is Kala Pharmaceuticals Inc share price today?

Kala Pharmaceuticals Inc (KALA) share price today is $0.3633

Can Indians buy Kala Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Kala Pharmaceuticals Inc (KALA) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in KALA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Kala Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Kala Pharmaceuticals Inc (KALA) via the Vested app. You can start investing in Kala Pharmaceuticals Inc (KALA) with a minimum investment of $1.

How to invest in Kala Pharmaceuticals Inc shares from India?

You can invest in shares of Kala Pharmaceuticals Inc (KALA) via Vested in three simple steps:

  • Click on Sign Up or Invest in KALA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Kala Pharmaceuticals Inc shares
What is Kala Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Kala Pharmaceuticals Inc (KALA) is $20.6. The 52-week low price of Kala Pharmaceuticals Inc (KALA) is $0.38.

What is Kala Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Kala Pharmaceuticals Inc (KALA) is

What is Kala Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Kala Pharmaceuticals Inc (KALA) is 8.34

What is Kala Pharmaceuticals Inc dividend yield?

The dividend yield of Kala Pharmaceuticals Inc (KALA) is 0.00%

What is the Market Cap of Kala Pharmaceuticals Inc?

The market capitalization of Kala Pharmaceuticals Inc (KALA) is $364.35M

What is Kala Pharmaceuticals Inc's stock symbol?

The stock symbol (or ticker) of Kala Pharmaceuticals Inc is KALA

How Can Investors Use Kala Pharmaceuticals Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Kala Pharmaceuticals Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Kala Pharmaceuticals Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Kala Pharmaceuticals Inc shares for Indian investors?

When investing in Kala Pharmaceuticals Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Kala Pharmaceuticals Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Kala Pharmaceuticals Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Kala Pharmaceuticals Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Kala Pharmaceuticals Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top